Activation of T gamma/delta cells by Borrelia glycolipids

疏螺旋体糖脂激活 T γ/δ 细胞

基本信息

  • 批准号:
    10418818
  • 负责人:
  • 金额:
    $ 23.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-06-04 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT The immune response to Borrelia burgdorferi is complex and at times, enigmatic. Most of the studies that have been done on the immunology of Lyme disease have focused on the role of the lipoproteins that are abundant in the spirochetes. We have shown that B. burgdorferi has unique glycolipids (MGal) and cholesteryl glycolipids (CGal) that have important biological and structural properties and include the ability to induce formation of antibodies. Gamma-delta (γδ) T cells straddle innate and adaptive immunity and are well known for responding to lipid antigens, but responsiveness has only rarely been demonstrated toward a specific bacterial lipid antigen. Based on this information, we tested MGal and CGal for activity to stimulate a specialized γδ T cell capable of long-lived memory formation and co-production of interferon gamma (IFNγ) and IL-17A, cytokines important for anti-pathogen immunity. Surprisingly, MGal was nearly as efficient as live Borrelia in the induction of IFNγ and IL-17A from these nonconventional T cells. These findings led to this proposal whereby we will evaluate the the capacity for MGal and CGal preparations to activate distinct γδ T cell subsets that contribute to anti-pathogen immunity. The function of the γδ T cells will be evaluated using unbiased and large scale cytokine high throughput assays in vitro and in mice, and thereafter, we plan a mechanistic approach to evaluate how these Borrelia lipids elicit γδ T cell functional responses. Given the complexity of the immune response in Lyme disease, this proposal will explore the role of diverse γδ T cell subsets in the response to B. burgdorferi infection. The manner of lipid- elicited γδ T cell function will be determined, and the corresponding functional response of the γδ T cells will be evaluated mechanistically. We anticipate that the γδ T cell-Borrelia axis will be an important contributor to the immune response during Lyme disease.
项目摘要/摘要 对伯氏疏螺旋体的免疫反应是复杂的,有时是谜一样的。大多数研究都有 关于莱姆病的免疫学研究主要集中在丰富的脂蛋白的作用上 在螺旋体中。我们已经证明伯氏杆菌具有独特的糖脂(MgAl)和胆固醇糖脂。 (CGal),具有重要的生物学和结构特性,包括诱导形成 抗体。伽马-三角洲(γδ)T细胞跨越先天免疫和获得性免疫,并以应答 对脂类抗原有反应,但对特定细菌脂类抗原的反应性很少。 基于这一信息,我们测试了镁铝和镁铝刺激一种特殊的γδT细胞的活性 长寿记忆的形成和干扰素γ和IL-17A的共同产生 抗病原体免疫。令人惊讶的是,镁铝在诱导干扰素γ和 这些非常规T细胞产生IL-17A。这些调查结果导致了这项建议,据此我们将评估 镁铝和镁铝制剂激活有助于抗病原体的γδT细胞亚群的能力 豁免权。γδT细胞的功能将使用无偏见和大规模的细胞因子高通量进行评估 在体外和在小鼠身上进行检测,然后,我们计划采用一种机械方法来评估这些疏螺旋体脂类如何 诱导γδT细胞功能反应。鉴于莱姆病免疫反应的复杂性,这项提议 将探索不同的γδT细胞亚群在应对伯氏杆菌感染中的作用。脂质的方式- 将确定激发的γδT细胞功能,并将相应的γδT细胞的功能应答 机械地评估。我们预计γδT细胞-疏螺旋体轴将是 莱姆病期间的免疫反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jorge L. Benach其他文献

A role for interleukin-1 in the pathogenesis of lyme disease
  • DOI:
    10.1016/s0176-6724(86)80114-6
  • 发表时间:
    1986-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Gregory Beck;Gail S. Habicht;Jorge L. Benach;James L. Coleman;Rita M. Lysik;Robert F. O’Brien
  • 通讯作者:
    Robert F. O’Brien
<em>Borrelia burgdorferi</em> lipopolysaccharide and its role in the pathogenesis of lyme disease
  • DOI:
    10.1016/s0176-6724(86)80115-8
  • 发表时间:
    1986-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Gail S. Habicht;Gregory Beck;Jorge L. Benach;James L. Coleman
  • 通讯作者:
    James L. Coleman
Lipid Raft Formation and Properties are Necessary and Sufficient to Explain the Properties of Membrane Domains in <em>B. Burgdorferi</em> and are Necessary for its Membrane Integrity
  • DOI:
    10.1016/j.bpj.2011.11.174
  • 发表时间:
    2012-01-31
  • 期刊:
  • 影响因子:
  • 作者:
    Timothy J. LaRocca;Priyadarshini Pathak;Salvatore Chiantia;John R. Silvius;Jorge L. Benach;Erwin London
  • 通讯作者:
    Erwin London
Isolation of the outer envelope from <em>Borrelia burgdorferi</em>
  • DOI:
    10.1016/s0176-6724(86)80112-2
  • 发表时间:
    1986-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    James L. Coleman;Jorge L. Benach;Gregory Beck;Gail S. Habicht
  • 通讯作者:
    Gail S. Habicht
The versatile roles of antibodies in Borrelia infections
抗体在伯氏疏螺旋体感染中的多效性作用
  • DOI:
    10.1038/nrmicro1149
  • 发表时间:
    2005-05-01
  • 期刊:
  • 影响因子:
    103.300
  • 作者:
    Sean E. Connolly;Jorge L. Benach
  • 通讯作者:
    Jorge L. Benach

Jorge L. Benach的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jorge L. Benach', 18)}}的其他基金

Activation of T gamma/delta cells by Borrelia glycolipids
疏螺旋体糖脂激活 T γ/δ 细胞
  • 批准号:
    10301808
  • 财政年份:
    2021
  • 资助金额:
    $ 23.93万
  • 项目类别:
IRACDA - The New York Consortium for the Advancement of Postdoctoral Scholars (NY CAPS)Phase II
IRACDA - 纽约博士后学者促进联盟 (NY CAPS) 第二阶段
  • 批准号:
    10163193
  • 财政年份:
    2012
  • 资助金额:
    $ 23.93万
  • 项目类别:
IRACDA - The New York Consortium for the Advancement of Postdoctoral Scholars (NY
IRACDA - 纽约博士后学者促进联盟 (NY
  • 批准号:
    9059114
  • 财政年份:
    2012
  • 资助金额:
    $ 23.93万
  • 项目类别:
IRACDA - The New York Consortium for the Advancement of Postdoctoral Scholars (NY CAPS)Phase II
IRACDA - 纽约博士后学者促进联盟 (NY CAPS) 第二阶段
  • 批准号:
    9915932
  • 财政年份:
    2012
  • 资助金额:
    $ 23.93万
  • 项目类别:
IRACDA - The New York Consortium for the Advancement of Postdoctoral Scholars (NY
IRACDA - 纽约博士后学者促进联盟 (NY
  • 批准号:
    8369166
  • 财政年份:
    2012
  • 资助金额:
    $ 23.93万
  • 项目类别:
IRACDA - The New York Consortium for the Advancement of Postdoctoral Scholars (NY
IRACDA - 纽约博士后学者促进联盟 (NY
  • 批准号:
    8518403
  • 财政年份:
    2012
  • 资助金额:
    $ 23.93万
  • 项目类别:
IRACDA - The New York Consortium for the Advancement of Postdoctoral Scholars (NY CAPS)Phase II
IRACDA - 纽约博士后学者促进联盟 (NY CAPS) 第二阶段
  • 批准号:
    9149880
  • 财政年份:
    2012
  • 资助金额:
    $ 23.93万
  • 项目类别:
IRACDA - The New York Consortium for the Advancement of Postdoctoral Scholars (NY
IRACDA - 纽约博士后学者促进联盟 (NY
  • 批准号:
    8657062
  • 财政年份:
    2012
  • 资助金额:
    $ 23.93万
  • 项目类别:
IRACDA - The New York Consortium for the Advancement of Postdoctoral Scholars (NY
IRACDA - 纽约博士后学者促进联盟 (NY
  • 批准号:
    8843894
  • 财政年份:
    2012
  • 资助金额:
    $ 23.93万
  • 项目类别:
PROBING THE MECHANISM OF COMPLEMENT-INDEPENDENT BACTERICIDAL ANTIBODIES
补体非依赖性杀菌抗体机制的探讨
  • 批准号:
    8172287
  • 财政年份:
    2010
  • 资助金额:
    $ 23.93万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 23.93万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 23.93万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 23.93万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.93万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 23.93万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 23.93万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 23.93万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 23.93万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 23.93万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 23.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了